Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma
- 1 November 2017
- journal article
- research article
- Published by Elsevier BV in Journal of Vascular and Interventional Radiology
- Vol. 28 (11), 1512-1519
- https://doi.org/10.1016/j.jvir.2017.06.016
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinomaOncotarget, 2016
- Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteriaBritish Journal of Surgery, 2016
- Combined locoregional treatment of patients with hepatocellular carcinoma: State of the artWorld Journal of Gastroenterology, 2016
- Long-term effectiveness of Radiofrequency Ablation for solitary small Hepatocellular Carcinoma: A retrospective analysis of 363 patientsDigestive and Liver Disease, 2013
- Transarterial embolization as neo‐adjuvant therapy pretransplantation in patients with hepatocellular carcinomaLiver International, 2013
- Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinomaWorld Journal of Gastroenterology, 2013
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2012
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic FactorsThe American Journal of Gastroenterology, 2012
- Portal Vein Embolization for Hepatocellular CarcinomaLiver Cancer, 2012
- Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinomaCancer, 2010